Cooper Companies (NASDAQ:COO) Posts Quarterly Earnings Results, Beats Estimates By $0.11 EPS

Cooper Companies (NASDAQ:COO) announced its quarterly earnings data on Thursday. The medical device company reported $1.21 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11, FiscalAI reports. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%. Cooper Companies updated its FY 2026 guidance to 4.580-4.660 EPS.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded up $1.68 during midday trading on Thursday, reaching $62.02. 3,967,583 shares of the company were exchanged, compared to its average volume of 2,227,799. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. Cooper Companies has a 1 year low of $58.89 and a 1 year high of $89.83. The stock has a fifty day simple moving average of $65.34 and a 200 day simple moving average of $74.64. The stock has a market cap of $12.10 billion, a P/E ratio of 30.70, a PEG ratio of 1.53 and a beta of 0.87.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Barclays lifted their target price on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, March 6th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research note on Saturday, February 28th. Needham & Company LLC increased their price objective on Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, March 6th. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the company an “overweight” rating in a research note on Monday. Finally, The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research note on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of “Moderate Buy” and an average price target of $87.00.

Cooper Companies News Roundup

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Quarterly EPS came in at $1.21, above the $1.10 consensus, showing better-than-expected profitability. View Press Release
• Positive Sentiment: Revenue reached $1.08 billion, topping the $1.05 billion estimate and signaling solid demand across the business. View Press Release
• Neutral Sentiment: Management raised FY 2026 EPS guidance to 4.58-4.66, which is slightly below the Street’s 4.62 estimate at the midpoint, suggesting the outlook is good but not a big upside surprise. View Press Release
• Neutral Sentiment: The company also kept revenue guidance roughly in line with expectations, limiting the chance of a major re-rating from guidance alone. View Press Release

Institutional Investors Weigh In On Cooper Companies

Institutional investors have recently added to or reduced their stakes in the business. American Trust purchased a new stake in Cooper Companies in the 4th quarter valued at approximately $216,000. Nicolet Advisory Services LLC purchased a new stake in Cooper Companies in the 3rd quarter valued at approximately $210,000. Siemens Fonds Invest GmbH boosted its holdings in Cooper Companies by 22.0% in the 3rd quarter. Siemens Fonds Invest GmbH now owns 2,782 shares of the medical device company’s stock valued at $191,000 after purchasing an additional 502 shares in the last quarter. Advisory Services Network LLC purchased a new stake in Cooper Companies in the 3rd quarter valued at approximately $163,000. Finally, Parallel Advisors LLC boosted its holdings in Cooper Companies by 72.8% in the 4th quarter. Parallel Advisors LLC now owns 1,583 shares of the medical device company’s stock valued at $130,000 after purchasing an additional 667 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.